Skip to main content
. Author manuscript; available in PMC: 2022 Jun 15.
Published in final edited form as: Bioorg Med Chem. 2021 May 1;40:116183. doi: 10.1016/j.bmc.2021.116183

Figure 4: The UV-VIS spectra for CoCo-IMP-1 and CoCo-IMP-1 with EDTA, captopril, and 1T5PA.

Figure 4:

Figure 4:

The concentration of IMP-1 used in this experiment is 300 μM. (A) The UV-VIS spectrum CoCo-IMP-1. (B) Enlarged view of the spectrum from 400 nm to 800 nm for CoCo-IMP-1. (C) The UV-VIS spectrum after addition of 1 (red) and 2 (green) equivalents of EDTA. (D) The UV-VIS spectrum after addition of 1 (red) and 2 (green) equivalents of Captopril. (E) The UV-VIS spectrum after addition of 1 (red) and 2 (green) equivalents of 1T5PA. (F) The enlarged view of the spectrum from wavelength 400 nm to 800 nm after addition 1 (red) and 2 (green) equivalents of 1T5PA.